L’Occitane International S.A. Receives Offer to Take Company Private

According to L'Occitane, 'The offer is particularly compelling in light of the prolonged low trading liquidity of the company’s shares, which makes it challenging for minority shareholders and vested option holders to sell a substantial amount of shares without adversely affecting the share price.'
According to L'Occitane, "The offer is particularly compelling in light of the prolonged low trading liquidity of the company’s shares, which makes it challenging for minority shareholders and vested option holders to sell a substantial amount of shares without adversely affecting the share price."
Heorshe at Adobe Stock

L’Occitane International S.A. has received a €1.7 billion take-private offer from L'Occitane chairman and current majority shareholder Reinold Geiger that values the organization at €6.0 billion.

That includes an offer price of HK$34.00 in cash per share, representing an approximately 60.83% premium to the undisturbed 60-trading day average closing price.

L'Occitane has established an independent board to review the offer, per the company.

Geiger argues that taking L'Occitane private will allow it "to pursue strategic investments and more efficiently implement strategies, free from the pressures of the capital markets’ expectations, regulatory costs and disclosure obligations, share price fluctuations, and sensitivity to short-term market and investor sentiment," per an official announcement.

According to L'Occitane, "The offer is particularly compelling in light of the prolonged low trading liquidity of the company’s shares, which makes it challenging for minority shareholders and vested option holders to sell a substantial amount of shares without adversely affecting the share price."

Geiger noted, “Our family has always taken a responsible, long-term view when it comes to developing our company. The cosmetics sector is undergoing profound changes, and our company has significantly transformed into a geographically balanced multi-brand group, marked by strategic acquisitions such as Elemis, Sol de Janeiro, and, most recently, Dr. Vranjes Firenze. The transaction we are launching today will enable us to focus on rebuilding the foundation for the long-term sustainable growth of our company.”

More in News